These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9858890)

  • 1. Mistletoe in immunology and the clinic (short review).
    Stein GM; Schietzel M; Büssing A
    Anticancer Res; 1998; 18(5A):3247-9. PubMed ID: 9858890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mistletoe in the treatment of cancer patients].
    Rostock M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of different antigens of mistletoe extracts by anti-mistletoe lectin antibodies.
    Stein GM; Pfüller U; Berg PA
    Cancer Lett; 1999 Jan; 135(2):165-70. PubMed ID: 10096425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM; Stettin A; Schultze J; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients are talking about ... Iscador (mistletoe).
    Decker G
    Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
    Pierach CA
    Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
    [No Abstract]   [Full Text] [Related]  

  • 11. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metaphorical aspects of mistletoe therapy in patients' experiences--a qualitative study].
    Konitzer M; Doering T; Fischer GC
    Forsch Komplementarmed Klass Naturheilkd; 2001 Apr; 8(2):68-79. PubMed ID: 11340313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mistletoe therapy. An alternative cancer treatment].
    Ernst E
    MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
    Stein G; Berg PA
    Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of mistletoe therapy in carcinoma patients].
    Rostock M; Unger C
    Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.
    Twardziok M; Meierhofer D; Börno S; Timmermann B; Jäger S; Boral S; Eggert A; Delebinski CI; Seifert G
    BMC Complement Altern Med; 2017 Apr; 17(1):237. PubMed ID: 28454538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticarcinogenic and antimetastatic activity of Iscador.
    Kuttan G; Menon LG; Antony S; Kuttan R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limits of mistletoe therapy in cancer patients].
    Hoffmann J
    Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
    Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.